insights_auto
Waarom is SBS gedaald 2,92%?
Meer informatiechevron_right
SBS:FRA
Stratec SE
€ 21,60
arrow_downward
-2,92%(-0,65) 1D
9 okt, 08:00:58 GMT+2 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor SBS genereren…
Openen
€ 21,60
Hoog
€ 21,60
Laag
€ 21,60
Beursw.
270,01 mln.
Gem. vol.
51,00
Volume
0,00
Dividend
2,78%
Kwartaaldividend
€ 0,15
Ex-dividenddatum
24 jun 2026
52 wk hoog
€ 32,05
52 wk laag
€ 16,38
WPA
€ -0,03
Uitstaande aandelen
11,96 mln.
Aantal medewerkers
1K
Openen
€ 21,60
Hoog
€ 21,60
Laag
€ 21,60
Beursw.
270,01 mln.
Gem. vol.
51,00
Volume
0,00
Dividend
2,78%
Kwartaaldividend
€ 0,15
Ex-dividenddatum
24 jun 2026
52 wk hoog
€ 32,05
52 wk laag
€ 16,38
WPA
€ -0,03
Uitstaande aandelen
11,96 mln.
Aantal medewerkers
1K
Nieuwsartikelen
Van webbronnen en nieuwspartners
AD HOC NEWS
·
13 uur geleden
mwb research downgrades Stratec stock as execution risks rise in 2026
Profiel
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics.
As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
Over Stratec SE